Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2025
Reporting Period: Event-based filing regarding corporate governance changes effective January 9, 2025.
Key Financial Metrics
This filing does not contain financial performance data. The document focuses exclusively on corporate governance and equity structure modifications. No revenue, profit, cash flow, margin, debt, or liquidity figures are provided in this text.
Material Changes
The Company's wholly-owned subsidiary, Mango & Peaches Corp. ("M&P"), filed a Certificate of Designations establishing a new class of equity:
- New Security: Series A Super Majority Voting Preferred Stock.
- Authorized Shares: 100 shares designated.
- Effective Date: January 9, 2025.
- Intended Recipient: Jacob Cohen, Chief Executive Officer, pursuant to his Amended and Restated Executive Employment Agreement dated December 13, 2024.
Terms of Series A Preferred Stock
The filing details specific rights and restrictions attached to the new preferred stock:
- Voting Rights: Holders possess super-majority voting power. They vote separately as a class with rights equal to 51% of the total vote on all shareholder matters. For example, if 10,000 common shares are outstanding, the Series A holders control 10,400 votes out of a total of 20,400.
- Dividends: No dividend accrual rights.
- Liquidation: No liquidation preference.
- Conversion: No conversion rights into common stock.
- Redemption: No redemption rights.
- Protective Provisions: M&P cannot amend its Certificate of Formation or Bylaws to adversely affect these rights, reclassify the stock, or designate new preferred series without the affirmative vote of at least 66-2/3% of the Series A Preferred Stock holders.
Investor Verification Checklist
- Verify the full text of the Certificate of Designations (Exhibit 3.1) for complete legal terms.
- Confirm the issuance of the 100 shares to Jacob Cohen and review the Amended and Restated Executive Employment Agreement filed on December 19, 2024.
- Assess the impact of the 51% voting control on future shareholder proposals and corporate governance decisions.
- Monitor for any future filings regarding the actual issuance of these shares to the CEO.